Latest filing published 18 May 2007 for BIOLASE, INC, €17k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeffrey W. Jones: trading record in brief
Jeffrey W. Jones discloses dealings in Biolase, Inc to SEC (Form 4). Between 24 August 2001 and 17 May 2007, the trades on record add up to 5 filings.
The open-market record is one-sided, with 5 purchases worth €79k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2007 to date brings 2 purchases and no sales.
Half of the purchases are above €17k and half below.
On 18 May 2007 came the latest disclosure, an open-market purchase for €17k in Biolase, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey W. Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$5.81Common StockSEC:0001209191-07-031318:0Canonical exit: 15 Aug 2007 (T+90)
- 4,500 shares@ US$5.80Common StockSEC:0001209191-07-031318:1Canonical exit: 15 Aug 2007 (T+90)
- 5,000 shares@ US$7.12Common StockSEC:0001358010-06-000019:0Canonical exit: 17 Aug 2006 (T+90)
- 2,000 shares@ US$7.12Common StockSEC:0001358010-06-000019:1Canonical exit: 17 Aug 2006 (T+90)
- 1,000 shares@ US$4.03Common StockSEC:0001358010-06-000006:0Canonical exit: 22 Nov 2001 (T+90)
5 of 5 declarations
